Search Results - "LIBANATI, Cesar" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

by McClung, Michael R, Grauer, Andreas, Boonen, Steven, Bolognese, Michael A, Brown, Jacques P, Diez-Perez, Adolfo, Langdahl, Bente L, Reginster, Jean-Yves, Zanchetta, Jose R, Wasserman, Scott M, Katz, Leonid, Maddox, Judy, Yang, Yu-Ching, Libanati, Cesar, Bone, Henry G
Published in The New England journal of medicine (30.01.2014)

Get full text

Journal Article Web Resource

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

by Cosman, Felicia, Crittenden, Daria B, Adachi, Jonathan D, Binkley, Neil, Czerwinski, Edward, Ferrari, Serge, Hofbauer, Lorenz C, Lau, Edith, Lewiecki, E. Michael, Miyauchi, Akimitsu, Zerbini, Cristiano A.F, Milmont, Cassandra E, Chen, Li, Maddox, Judy, Meisner, Paul D, Libanati, Cesar, Grauer, Andreas
Published in The New England journal of medicine (20.10.2016)

Get full text

Journal Article

One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study

One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study

by Lewiecki, E Michael, Dinavahi, Rajani V, Lazaretti‐Castro, Marise, Ebeling, Peter R, Adachi, Jonathan D, Miyauchi, Akimitsu, Gielen, Evelien, Milmont, Cassandra E, Libanati, Cesar, Grauer, Andreas
Published in Journal of bone and mineral research (01.03.2019)

Get full text

Journal Article

Romosozumab and antiresorptive treatment: the importance of treatment sequence

Romosozumab and antiresorptive treatment: the importance of treatment sequence

by Cosman, Felicia, Kendler, David L., Langdahl, Bente L., Leder, Benjamin Z., Lewiecki, E. Michael, Miyauchi, Akimitsu, Rojeski, Maria, McDermott, Michele, Oates, Mary K., Milmont, Cassandra E., Libanati, Cesar, Ferrari, Serge
Published in Osteoporosis international (01.06.2022)

Get full text

Journal Article

Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial

Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial

by Takada, Junichi, Dinavahi, Rajani, Miyauchi, Akimitsu, Hamaya, Etsuro, Hirama, Toshiyasu, Libanati, Cesar, Nakamura, Yoichi, Milmont, Cassandra E., Grauer, Andreas
Published in Journal of bone and mineral metabolism (01.05.2020)

Get full text

Journal Article

$One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data$

One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data

by Khalid, Sara, Reyes, Carlen, Ernst, Martin, Delmestri, Antonella, Toth, Emese, Libanati, Cesar, Abrahamsen, Bo, Prieto-Alhambra, Daniel
Published in Osteoporosis international (01.01.2022)

Get full text

Journal Article

$Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial$

Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial

by Miyauchi, Akimitsu, Hamaya, Etsuro, Yang, Wenjing, Nishi, Kiyoshi, Libanati, Cesar, Tolman, Cae, Shimauchi, Junichiro
Published in Journal of bone and mineral metabolism (01.03.2021)

Get full text

Journal Article

Differing effects of denosumab and alendronate on cortical and trabecular bone

Differing effects of denosumab and alendronate on cortical and trabecular bone

by Zebaze, Roger M, Libanati, Cesar, Austin, Matthew, Ghasem-Zadeh, Ali, Hanley, David A, Zanchetta, Jose R, Thomas, Thierry, Boutroy, Stephanie, Bogado, Cesar E, Bilezikian, John P, Seeman, Ego
Published in Bone (New York, N.Y.) (01.02.2014)

Get full text

Journal Article

Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate

Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate

by Seeman, Ego, Delmas, Pierre D, Hanley, David A, Sellmeyer, Deborah, Cheung, Angela M, Shane, Elizabeth, Kearns, Ann, Thomas, Thierry, Boyd, Steven K, Boutroy, Stephanie, Bogado, Cesar, Majumdar, Sharmila, Fan, Michelle, Libanati, Cesar, Zanchetta, Jose
Published in Journal of bone and mineral research (01.08.2010)

Get full text

Journal Article

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

by Eastell, Richard, Christiansen, Claus, Grauer, Andreas, Kutilek, Stepan, Libanati, Cesar, McClung, Michael R, Reid, Ian R, Resch, Heinrich, Siris, Ethel, Uebelhart, Daniel, Wang, Andrea, Weryha, Georges, Cummings, Steve R
Published in Journal of bone and mineral research (01.03.2011)

Get full text

Journal Article

Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology

Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology

by Zysset, Philippe, Pahr, Dieter, Engelke, Klaus, Genant, Harry K, McClung, Michael R, Kendler, David L, Recknor, Christopher, Kinzl, Michael, Schwiedrzik, Jakob, Museyko, Oleg, Wang, Andrea, Libanati, Cesar
Published in Bone (New York, N.Y.) (01.12.2015)

Get full text

Journal Article

Fracture Risk in Men and Women With Vertebral Fractures Identified Opportunistically on Routine Computed Tomography Scans and Not Treated for Osteoporosis: An Observational Cohort Study

Fracture Risk in Men and Women With Vertebral Fractures Identified Opportunistically on Routine Computed Tomography Scans and Not Treated for Osteoporosis: An Observational Cohort Study

by Skjødt, Michael Kriegbaum, Nicolaes, Joeri, Smith, Christopher Dyer, Olsen, Kim Rose, Cooper, Cyrus, Libanati, Cesar, Abrahamsen, Bo
Published in JBMR plus (01.05.2023)

Get full text

Journal Article

Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension

Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension

by Miyauchi, Akimitsu, Dinavahi, Rajani V., Crittenden, Daria B., Yang, Wenjing, Maddox, Judy C., Hamaya, Etsuro, Nakamura, Yoichi, Libanati, Cesar, Grauer, Andreas, Shimauchi, Junichiro
Published in Archives of osteoporosis (05.06.2019)

Get full text

Journal Article

Correction to: Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial

Correction to: Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trial

by Takada, Junichi, Dinavahi, Rajani, Miyauchi, Akimitsu, Hamaya, Etsuro, Hirama, Toshiyasu, Libanati, Cesar, Nakamura, Yoichi, Milmont, Cassandra E., Grauer, Andreas
Published in Journal of bone and mineral metabolism (01.07.2020)

Get full text

Journal Article

Skeletal responses to romosozumab after 12 months of denosumab

Skeletal responses to romosozumab after 12 months of denosumab

by McClung, Michael R., Bolognese, Michael A., Brown, Jacques P., Reginster, Jean‐Yves, Langdahl, Bente L., Shi, Yifei, Timoshanko, Jen, Libanati, Cesar, Chines, Arkadi, Oates, Mary K.
Published in JBMR plus (01.07.2021)

Get full text

Journal Article

Preparing the Leaders of Tomorrow: Learnings from a Two-Year Community of Practice in Fragility Fractures

Preparing the Leaders of Tomorrow: Learnings from a Two-Year Community of Practice in Fragility Fractures

by Murray, Suzanne, Langdahl, Bente, Casado, Enrique, Brooks, Keyla, Libanati, Cesar, Di Lecce, Livio, Lazure, Patrice
Published in Journal of CME (31.12.2022)

Get full text

Journal Article

The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study

The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study

by Geusens, Piet, Oates, Mary, Miyauchi, Akimitsu, Adachi, Jonathan D, Lazaretti‐Castro, Marise, Ebeling, Peter R, Perez Niño, Carlos Augusto, Milmont, Cassandra E, Grauer, Andreas, Libanati, Cesar
Published in JBMR plus (01.10.2019)

Get full text

Journal Article

$Automated detection of vertebral fractures in CT using 3D convolutional neural networks$

Automated detection of vertebral fractures in CT using 3D convolutional neural networks

by Nicolaes, Joeri, Raeymaeckers, Steven, Robben, David, Wilms, Guido, Vandermeulen, Dirk, Libanati, Cesar, Debois, Marc
Published in Bone Reports (01.10.2020)

Get full text

Journal Article

Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals

Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals

by Cosman, Felicia, Libanati, Cesar, Deignan, Cynthia, Yu, Zhigang, Wang, Zhenxun, Ferrari, Serge, Beck Jensen, Jens‐Erik, Peris, Pilar, Bertoldo, Francesco, Lespessailles, Eric, Hesse, Eric, Cummings, Steven R
Published in JBMR plus (01.11.2021)

Get full text

Journal Article

Kinetic reconstruction of the cancellous (Cn) and endocortical (Ec) remodelling unit reveals a net positive bone balance (BB) after 12 months of treatment with romosozumab

Kinetic reconstruction of the cancellous (Cn) and endocortical (Ec) remodelling unit reveals a net positive bone balance (BB) after 12 months of treatment with romosozumab

by Eriksen, Erik F., Boyce, Rogely W., Shi, Yifei, Brown, Jacques P., Horlait, Stéphane, Libanati, Cesar, Chapurlat, Roland, Chavassieux, Pascale
Published in Bone Reports (01.04.2021)

Get full text

Journal Article

1
2
3
4
5
6
7
Next
[7]